2026 NPPES data Primary Podiatric Medicine Podiatrist NPI 1033565452
Verify on CMS →

MICHAEL MILAD

Primary Podiatric Medicine Podiatrist in BAYONNE, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
296
Medicare Part D claims · 165 beneficiaries · Primary Podiatric Medicine Podiatrist avg: 322
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]
Industry payments
$1.3K
13 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MICHAEL MILAD is a Primary Podiatric Medicine Podiatrist ([object Object]) practicing in BAYONNE, New Jersey with a Medicare Part D prescribing footprint of 296 claims across 165 beneficiaries — 16% brand-name prescribing . Their CMS MIPS Final Score of 0/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.3K across 13 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MICHAEL MILAD reported a CMS MIPS final score of 0 out of 100, below the 83.1 national average, and filed 296 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MICHAEL MILAD at a glance

Below national average

NPI registry status

Active

Issued 05/05/2016

NPI 1033565452

Primary specialty

Primary Podiatric Medicine Podiatrist

Niche

1,077 US NPIs in this specialty

Medicare Part D claims

296 8% vs specialty avg

2023 prescription claims

Specialty avg: 322

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in New Jersey

How Primary Podiatric Medicine Podiatrist compares to other specialties among New Jersey providers

New Jersey providers

Primary Podiatric Medicine Podiatrist share within New Jersey

1. Primary Podiatric Medicine Podiatrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Primary Podiatric Medicine Podiatrist share within New Jersey

Medicare quality performance — MIPS

MICHAEL MILAD's 2023 MIPS final score plotted against the Primary Podiatric Medicine Podiatrist national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Primary Podiatric Medicine Podiatrist) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Primary Podiatric Medicine Podiatrist) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHAEL MILAD is a Primary Podiatric Medicine Podiatrist provider practicing in BAYONNE, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1033565452. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MICHAEL MILAD appears in the CMS NPPES registry as a Primary Podiatric Medicine Podiatrist provider at 834 AVENUE C, BAYONNE, NJ, 07002, with a listed phone of (732) 926-7733. NPI 1033565452 was issued on 05/05/2016. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MILAD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 296 prescription claims written by this provider, covering 165 Medicare beneficiaries and totaling roughly $9K in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Primary Podiatric Medicine Podiatrist is a narrow specialty nationwide, with 1,077 enrolled providers across 50 states and an average of 322 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

834 AVENUE C
BAYONNE, NJ 07002

Provider Details

NPI 1033565452
Specialty Primary Podiatric Medicine Podiatrist
Gender Male
NPI Issued 05/05/2016

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MICHAEL MILAD. Source: openpaymentsdata.cms.gov.

Total received

$1.3K

Largest payer

Seapearl East, Inc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

MICHAEL MILAD — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 296 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

296
Total Claims
$9K
Total Drug Cost
165
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
303
Total Day Supply
5,632
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$4K
Generic Drug Cost
$5K
Antibiotic Claims
53

Patient Demographics

Average Patient Age
73.0 years
Avg HCC Risk Score
1.48
Gender Split
51% female / 49% male
Age Distribution
<65: 16, 65-74: 74, 75-84: 52, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Meloxicam
56
Ammonium Lactate
47
Clindamycin Hcl
28
Silver Sulfadiazine
25
Methylprednisolone
20
Ciclopirox
19
Cephalexin
16
Ssd
Silver Sulfadiazine
16
Clobetasol Propionate
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Primary Podiatric Medicine Podiatrist Overview

How MICHAEL MILAD fits within the Primary Podiatric Medicine Podiatrist landscape nationally.

1,077
Primary Podiatric Medicine Podiatrist Providers in US
50
States with Primary Podiatric Medicine Podiatrist
322
Avg Claims per Provider

MICHAEL MILAD's 296 claims are below the specialty average of 322.

Nearby Primary Podiatric Medicine Podiatrist Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as MILAD.

Compare Primary Podiatric Medicine Podiatrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHAEL MILAD's specialty?
MICHAEL MILAD specializes in Primary Podiatric Medicine Podiatrist and practices in BAYONNE, New Jersey.
How much does MICHAEL MILAD prescribe under Medicare Part D?
In 2023, MICHAEL MILAD wrote 296 Medicare Part D claims totaling $9K in drug costs for 165 beneficiaries.
What is MICHAEL MILAD's Medicare quality score?
MICHAEL MILAD has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MICHAEL MILAD located?
MICHAEL MILAD is located at 834 AVENUE C, BAYONNE, NJ, 07002. Phone: (732) 926-7733.
What is MICHAEL MILAD's NPI number?
MICHAEL MILAD's National Provider Identifier (NPI) is 1033565452, issued on 05/05/2016.
Does MICHAEL MILAD prescribe more brand-name or generic drugs?
MICHAEL MILAD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $4K in brand drug costs.
How many Primary Podiatric Medicine Podiatrist providers are there in the US?
There are 1,077 Primary Podiatric Medicine Podiatrist providers across 50 states in the US. The average Primary Podiatric Medicine Podiatrist provider writes 322 Medicare Part D claims per year.
What drugs does MICHAEL MILAD prescribe most often?
Based on 2023 Medicare Part D data, MICHAEL MILAD's most frequently prescribed drugs include Meloxicam, Ammonium Lactate, Clindamycin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHAEL MILAD accept Medicare?
MICHAEL MILAD appears in CMS Medicare data with 296 Part D claims and 165 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHAEL MILAD's credentials?
MICHAEL MILAD's NPI is 1033565452. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology